Bone Grafts And Substitutes Industry Revenue, Chain Supply, Key Market Driver Analysis Forecast 2024

Bone Grafts And Substitutes Industry Revenue, Chain Supply, Key
Market Driver Analysis Forecast 2024
“Bone Grafts and Substitutes market was valued at over USD 2.3 billion in
2015 and is anticipated to reach over USD 3.6 billion by 2024, with a CAGR of
5.2%. Global bone graft and substitute market is expected to grow rapidly due
to the increase in geriatric population.”
The global Bone Grafts and Substitutes Market was valued at over USD 2.3 billion in 2015 and is anticipated to
reach over USD 3.6 billion by 2024, with a CAGR of 5.2%. Global bone graft and substitute market is expected
to grow rapidly due to the increase in geriatric population, changes in technologies and launch of innovative
products. Furthermore, increase in number of accidents leading to fractures, weakness of bones and
reimbursement policy. The other factors driving the market growth are the increase in medical awareness,
taking as minimum risk as they can. Hence, leading to more patient satisfaction and decrease in mortality rate.
Bone graft and substitute is bioresorbable, osteoinductive (induction of host’s stem cells for proliferation),
osteogenesis (origination of new bone from live cells in host body), osteoconductive (inward movement of
mesenchymal cells that are involved in formation of bones) and cost effective.
On the basis of type of technology, Bone graft and substitute market is classified into Autograft, Allograft and
Bone graft substitutes. Autograft- Bone is harvested from within the host’s body. So, there is less risk of rejection
as it is from the patient’s body. But, there are some complications with it as additional post-operative
procedures are required in for taking out the cells or bones from the other part of the body. To overcome these
issues, the allograft method is used . Allograft consists of demineralized bone matrix, freeze dried bones and
fresh frozen bones. In allograft, the source is corpse and as it is easily available in different sizes and shapes and
also the risk to the patient is negligible. However, there are high chances of infection, and to mitigate these
risks, the sterilized method using freeze dried bones and fresh frozen bone is preferred.
Request Sample Copy of this Market Research @
https://www.millioninsights.com/industry-reports/bone-grafts-and-substitutes-market/request-sample

The distribution for allograft is done through regional tissue banks. Bone graft substitute includes Bone
morphogeneticproteins (rh-BMP2, rhBMP7) and along with some growth factors (transforming growth factorbetaTGF,
fibroblast growth factor FGF and Platelet Derived growth factor PDGF) helps in bone reconstruction,
bone repair and regeneration; Synthetic Bone graft are created chemically using Hydroxyapatite, Tricalcium
phosphate, Calcium sulphate, Calcium phosphate and some degradable and non-degradable polymers are also
used. It is an alternative to allograft and autograft. BMP has some benefits over allograft by decreasing the risk
of morbidity and disease transmission.
Bone graft substitute is segmented on the basis of application- Spinal fusion, Long bone, Foot and ankle,
Craniomaxilofacial, Joint reconstruction and Dental. Mostly, in long bones and spinal fusion, Synthetic bone graft
is used while in Foot and ankle, Craniomaxilofacial, Joint reconstruction and Dental, allograft is used. The end
use of Bone graft and substitutes are the doctors. For improved growth, cell therapy technique is used with
bone graft. In cell therapy, soft tissue is injected for the treatment. It includes bone marrow and platelet rich
plasma with bone graft. Due to this complementary use of products with bone graft, there is an increase in
market share. Platelets help in releasing the growth factors and thus improving the osteoinductive mechanism
of bone graft.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/bone-grafts-and-substitutes-market
Geographically, it is segmented in North America- U.S and Canada, Europe- U.K and Germany, Asia Pacific- China
and Japan, Latin America- Brazil and Mexico, Middle East- South Africa. North America is one of the fastest
growing country. Some of the reasons behind this are the growing geriatric population, increase in number of
surgeries, more support by the government regarding reimbursement. According to Orthopedic Biomaterial
market in U.S, around $2.5 billion sales is generated by Bone grafting. It is expected that the growth will increase
to $2.8 billion by 2022. Each year, more than 2.2 million bone grafting are performed. The major key players in
the market are Wright Medical Group, Baxter International, Medtronic plc, Zimmer Inc., Allosource, Stryker
Corporation, Depuy Synthes, Orthofix Holding Inc., and NuvasineInc.
See More Reports of this Category by Million Insights @
https://www.millioninsights.com/industry/biotechnology

Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our
representatives strive to understand diverse client requirements and cater to the same with the
most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: ryan@millioninsights.com
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: sales@millioninsights.com
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016
India
Phone: 91-20-65300184